|1.||Huang, Kun: 4 articles (02/2015 - 10/2013)|
|2.||Bitan, Gal: 4 articles (01/2014 - 01/2009)|
|3.||Röcken, Christoph: 4 articles (08/2009 - 05/2004)|
|4.||Ishii, Yoshitaka: 3 articles (05/2015 - 10/2005)|
|5.||Gong, Hao: 3 articles (01/2015 - 10/2013)|
|6.||Belfort, Georges: 3 articles (08/2014 - 06/2009)|
|7.||Fantini, Jacques: 3 articles (07/2014 - 01/2010)|
|8.||Yahi, Nouara: 3 articles (07/2014 - 01/2010)|
|9.||Yamada, Masahito: 3 articles (07/2014 - 11/2008)|
|10.||Lee, Virginia M-Y: 3 articles (01/2012 - 06/2004)|
10/01/2010 - "Recent studies clearly demonstrated that several types of pathogenic amyloid proteins acted as agents that could transmit amyloidosis by means of a prion-like mechanism. "
05/28/2010 - "We report two cases of small bowel amyloidosis: the former characterized by focal deposition of amyloid proteins exclusively within blood vessel walls of the terminal ileum, the latter characterized by diffuse intestinal involvement observed on MRI and PET/CT studies."
01/01/2010 - "Studies on the molecular pathogenesis of amyloidoses have shown that the plasma membrane plays an important role in amyloidogenesis and cytotoxicity induced by amyloidogenic proteins. "
02/15/2015 - "How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins."
01/01/2015 - "In kidneys affected by amyloidosis, the amyloid proteins are predominantly deposited along vessels, especially the small vessels including glomerular capillary loops. "
|2.||Alzheimer Disease (Alzheimer's Disease)
06/01/2006 - "This article puts forward the hypothesis that the Low Density Lipid Receptor (LDLR) is one of the molecules that is involved in the clearance of amyloid proteins in the brain and that it may play a role in Alzheimer's Disease (AD) via its up-regulation by statins. "
07/01/2011 - "We will discuss how elucidating the genotype-to-phenotype relationships of familial forms of Alzheimer's disease has highlighted the importance of the misfolding and altered proteostasis of two otherwise soluble proteins, amyloid β-protein and tau, suggesting mechanism-based therapeutic targets that have led to clinical trials."
12/15/2015 - "APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease."
01/01/2014 - "Self-assembly of the intrinsically unstructured proteins, amyloid beta (Aβ) and alpha synclein (αSyn), are associated with Alzheimer's Disease, and Parkinson's and Lewy Body Diseases, respectively. "
02/01/2013 - "Alzheimer's disease (AD) is a neurodegenerative process characterized, in part, by the accumulation of beta-amyloid proteins (Aβ) in the brain. "
05/01/2004 - "The present study has investigated whether recombinant human CathB, CathK, and CathL are able to degrade AL(VlambdaVI) amyloid proteins and AL amyloid deposits. "
01/01/2016 - "In common with other misfolded and aggregated proteins, amyloid formation involves aggregation of monomers of hIAPP into oligomers, fibrils, and ultimately mature amyloid deposits. "
01/01/2015 - "Several pro-amyloid proteins can produce amyloid deposits in the heart. "
09/01/2009 - "The disease is characterized by accumulation of misfolded neuronal proteins, amyloid and tau, into insoluble aggregates known as extracellular senile plaques and intracellular neurofibrillary tangles, respectively. "
07/01/1992 - "In 9 nerves, the amyloid deposits were too small to allow adequate immunohistochemical characterization of amyloid proteins in serial sections. "
|4.||Neurodegenerative Diseases (Neurodegenerative Disease)
01/01/2012 - "Recent studies strongly implicate smaller aggregates of amyloid proteins as the toxic species underlying these neurodegenerative diseases. "
09/01/2015 - "The interactions between nanomaterials (NMs) and amyloid proteins are central to the nanotechnology-based diagnostics and therapy in neurodegenerative disorders such as Alzheimer's and Parkinson's. "
07/05/2015 - "Certain neurodegenerative diseases are thought to be initiated by the aggregation of amyloidogenic proteins. "
01/01/2015 - "Amyloidogenic proteins have long been linked to neurodegenerative diseases. "
01/01/2015 - "The aggregation of amyloid proteins into fibrils is associated with neurodegenerative diseases such as Alzheimer's and Type II Diabetes. "
|5.||Prion Diseases (Transmissible Spongiform Encephalopathies)
11/12/2014 - "These vesicles also have a sinister role in the propagation of toxic amyloid proteins in neurodegenerative conditions, including prion diseases and Alzheimer's and Parkinson's diseases, in inducing neuroinflammation by exchange of information between the neurons and glia, as well as in aiding tumor progression in the brain by subversion of normal cells. "
01/02/2013 - "The growing interest in membrane interactions of amyloidogenic proteins indicates that lipid binding and the regulation of membrane potential are critical to the onset and progression of neurodegenerative diseases such as Parkinson's (PD), Alzheimer's (AD), and prion diseases. "
11/01/2009 - "We hypothesize that this selective extraction approach may also be applicable for the removal of other amyloidogenic proteins that lead to neurodegenerative diseases (e.g., Alzheimer's, Parkinson's, Huntington's, mad cow, and prion diseases) from their continuous phase, e.g. "
06/03/2009 - "These core-shell nanoparticles may therefore be also useful for the inhibition of conformational changes of other amyloidogenic proteins that lead to neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, mad cow and prion diseases."
12/01/2010 - "Despite the phagocytic machinery available to microglia the aberrant amyloid proteins produced during Alzheimer's and prion disease, amyloid-β and PrP(Sc), are inefficiently cleared. "
|1.||Amyloid (Amyloid Fibrils)
|2.||Apolipoproteins E (ApoE)
|5.||Fixatives (Pickling Agents)
|7.||Proteins (Proteins, Gene)
|2.||Renal Dialysis (Hemodialysis)
|3.||Drug Therapy (Chemotherapy)
|4.||Investigational Therapies (Experimental Therapy)